Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2014 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori.
Chahine C, Moukhachen O, Chedid M, Araj GF, Sharara AI. Chahine C, et al. Am J Health Syst Pharm. 2001 Oct 1;58(19):1819-23. doi: 10.1093/ajhp/58.19.1819. Am J Health Syst Pharm. 2001. PMID: 11596697 Clinical Trial.
The efficacy and safety of two ultrashort azithromycin-containing regimens for Helicobacter pylori infection were studied. ...In both groups, patients received lansoprazole 30 mg p.o. twice daily on day 1 and, on days 2 and 3, lansoprazole 30 mg p.o. twice daily, amoxicill …
The efficacy and safety of two ultrashort azithromycin-containing regimens for Helicobacter pylori infection were studied. ...In both …
Azithromycin hydrates-implications of processing-induced phase transformations.
Sundaramurthi P, Suryanarayanan R. Sundaramurthi P, et al. J Pharm Sci. 2014 Oct;103(10):3095-106. doi: 10.1002/jps.24084. Epub 2014 Aug 19. J Pharm Sci. 2014. PMID: 25139082
According to label claims, in commercial solid dosage forms, azithromycin (AZI) exists either as a monohydrate (MH) or as a dihydrate (DH). ...On the other hand, dehydration of MH (at 60C) resulted in amorphization with no intermediate crystalline anhydrate. Diagnos …
According to label claims, in commercial solid dosage forms, azithromycin (AZI) exists either as a monohydrate (MH) or as a dihydrate …